BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16034631)

  • 1. [Acneiform skin eruption in patients with metastatic colorectal carcinoma].
    Gethöffer K; Schneider LA; Peters T; Weber L; Scharffetter-Kochanek K
    Hautarzt; 2006 Jul; 57(7):628-31. PubMed ID: 16034631
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosaceiform eruption induced by cetuximab.
    Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
    Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
    [No Abstract]   [Full Text] [Related]  

  • 3. Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.
    Eames T; Kroth J; Flaig MJ; Ruzicka T; Wollenberg A
    Acta Derm Venereol; 2010 Mar; 90(2):202-3. PubMed ID: 20169314
    [No Abstract]   [Full Text] [Related]  

  • 4. Images in clinical medicine. Cetuximab-associated acneiform eruption.
    Moss JE; Burtness B
    N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
    [No Abstract]   [Full Text] [Related]  

  • 5. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
    Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
    Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acneiform eruptions induced by cetuximab].
    Walon L; Gilbeau C; Lachapelle JM
    Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a pre-emptive skin treatment regimen on skin toxicities of anti-epidermal growth factor receptor monoclonal antibodies: more questions than answers.
    Rother M
    J Clin Oncol; 2010 Sep; 28(27):e474; author reply e475-6. PubMed ID: 20585089
    [No Abstract]   [Full Text] [Related]  

  • 9. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
    Cholongitas E; Pipili C; Ioannidou D
    J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer.
    Ouwerkerk J; Boers-Doets C
    Eur J Oncol Nurs; 2010 Sep; 14(4):337-49. PubMed ID: 20580896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
    Ocvirk J; Cencelj S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acneiform eruption secondary to cetuximab].
    Herrera-Acosta E; Martín-Ezquerra G; Iglesias M; Umbert P
    Actas Dermosifiliogr; 2005 May; 96(4):252-4. PubMed ID: 16476378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecthymatous skin eruption during therapy with cetuximab.
    Navarini AA; Kamacharova I; Kerl K; Donghi D; Cozzio A
    Eur J Dermatol; 2011; 21(2):282-3. PubMed ID: 21489913
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
    Gencoglan G; Ceylan C
    Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
    Taguchi K; Fukunaga A; Okuno T; Nishigori C
    J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies.
    Segaert S; Tabernero J; Chosidow O; Dirschka T; Elsner J; Mancini L; Maughan T; Morere JF; Santoro A; Sobrero A; Van Cutsem E; Layton A
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):599-606. PubMed ID: 16033478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous side effects of EGF receptor inhibitors].
    Nassar D; Soutou B; Aractingi S
    Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer.
    Jo JC; Hong YS; Kim KP; Lee JL; Kim HJ; Lee MW; Lim SB; Yu CS; Kim JC; Kim JH; Kim TW
    Eur J Dermatol; 2013; 23(1):77-82. PubMed ID: 23238388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of EGFR inhibitors in colorectal cancer: is it clinically efficacious and cost-effective?
    Lien K; Berry S; Ko YJ; Chan KK
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):81-100. PubMed ID: 25400031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.